PREDICTION OF LATE BREAST CANCER RECURRENCE BY THE ROR (PAM50) SCORE IN POSTMENOPAUSAL WOMEN IN THE TRANSATAC COHORT

被引：0
|
作者：
Cuzick, J. [1 ]
Sestak, I. [1 ]
Ferree, S. [2 ]
Cowens, J. W. [2 ]
Dowsett, M. [3 ]
机构：
[1] Queen Mary Univ London, Ctr Epidemiol Math & Stat, London, England
[2] NanoString Technol, Nanostring Technol, Seattle, WA USA
[3] Breakthrough Res Ctr, Acad Dept Biochem, London, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [1] Race and recurrence by PAM50 intrinsic subtype and ROR-PT score: The Carolina breast cancer study
    Sun, Xuezheng
    Reeder-Hayes, Katherine E.
    Kirk, Erin L.
    Olsson, Linnea
    Tse, Chiu-Kit
    Bell, Mary B.
    Earp, H. Shelton
    Carey, Lisa A.
    Perou, Charles M.
    Olshan, Andrew F.
    Troester, Melissa A.
    CANCER RESEARCH, 2018, 78 (04)
  • [2] The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
    Filipits, Martin
    Nielsen, Torsten O.
    Rudas, Margaretha
    Greil, Richard
    Stoeger, Herbert
    Jakesz, Raimund
    Bago-Horvath, Zsuzsanna
    Dietze, Otto
    Regitnig, Peter
    Gruber-Rossipal, Christine
    Mueller-Holzner, Elisabeth
    Singer, Christian F.
    Mlineritsch, Brigitte
    Dubsky, Peter
    Bauernhofer, Thomas
    Hubalek, Michael
    Knauer, Michael
    Trapl, Harald
    Fesl, Christian
    Schaper, Carl
    Ferree, Sean
    Liu, Shuzhen
    Cowens, J. Wayne
    Gnant, Michael
    CLINICAL CANCER RESEARCH, 2014, 20 (05) : 1298 - 1305
  • [3] Prediction of late distant recurrence after 5 years of endocrine treatment: A combined analysis of 2485 patients from the ABCSG-8 and transATAC studies using the PAM50 risk of recurrence (ROR) score
    Sestak, I.
    Cuzick, J.
    Dowsett, M.
    Filipits, M.
    Dubsky, P.
    Cowens, W.
    Ferree, S.
    Schaper, C.
    Fesl, C.
    Gnant, M.
    CANCER RESEARCH, 2013, 73
  • [4] Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer
    Lien, Tonje
    Ohnstad, Hege Oma
    Lingjaerde, Ole Christian
    Vallon-Christersson, Johan
    Aaserud, Marit
    Sveli, My Anh Tu
    Borg, Ake
    OSBREAC, Oystein
    Garred, Oystein
    Borgen, Elin
    Naume, Bjorn
    Russnes, Hege
    Sorlie, Therese
    CANCERS, 2021, 13 (23)
  • [5] Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
    Godina, Christopher
    Belting, Mattias
    Vallon-Christersson, Johan
    Isaksson, Karolin
    Bosch, Ana
    Jernstrom, Helena
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [6] Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
    Christopher Godina
    Mattias Belting
    Johan Vallon-Christersson
    Karolin Isaksson
    Ana Bosch
    Helena Jernström
    Scientific Reports, 14
  • [7] Clinical validation of the PAM50 risk of recurrence (ROR) score for predicting residual risk of distant-recurrence (DR) after endocrine therapy in postmenopausal women with ER plus early breast cancer (EBC): An ABCSG study
    Gnant, M.
    Filipits, M.
    Mlineritsch, B.
    Dubsky, P.
    Jakesz, R.
    Kwasny, W.
    Fitzal, F.
    Rudas, M.
    Knauer, M.
    Singer, C.
    Greil, R.
    Ferree, S.
    Storhoff, J.
    Cowens, J. W.
    Schaper, C.
    Liu, S.
    Nielsen, T.
    CANCER RESEARCH, 2012, 72
  • [8] Predicting local recurrence using PAM50 in postmenopausal endocrine responsive breast cancer patients.
    Fitzal, Florian
    Filipits, Martin
    Fesl, Christian
    Rudas, Margaretha
    Dubsky, Peter Christian
    Bartsch, Rupert
    Regitnig, Peter
    Bauernhofer, Thomas
    Greil, Richard
    Leitner, Gerhard
    Knauer, Michael
    Hubalek, Michael
    Fridrik, Michael A.
    Herz, Walter
    Dietze, Otto
    Cowens, John W.
    Ferree, Sean
    Nielsen, Torsten O.
    Gnant, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] PAM50 breast cancer subtyping and risk of recurrence in a population-based cohort.
    Bernard, Philip
    Weltzien, Erin
    Stijleman, Inge
    Kroenke, Candyce H.
    Davis, Carole
    Kwan, Marilyn L.
    Quesenberry, Charles
    Castillo, Adrienne
    Habel, Laurel
    Factor, Rachel
    Kushi, Larry
    Sweeney, Carol
    Caan, Bette
    CANCER RESEARCH, 2013, 73 (08)
  • [10] Prediction of NSCLC Survival With the PAM50 Breast Cancer Signature
    Siegfried, J. M.
    Lin, Y.
    Dacic, S.
    Stabile, L. P.
    Diergaarde, B.
    Lin, H.
    Nukui, T.
    Romkes, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S71 - S72
12345